Nutrtion Guide Home > NCI Cancer Thesaurus > Ibritumomab Tiuxetan

Ibritumomab Tiuxetan
Definition and Synonyms

Definition: ZEVALIN (Ibritumomab Tiuxetan) is the immunoconjugate resulting from a stable thiourea covalent bond between the monoclonal antibody Ibritumomab and the linker-chelator tiuxetan. This linker-chelator provides a high affinity, conformationally restricted chelation site for Indium-111 or Yttrium-90. The ZEVALIN therapeutic regimen is administered in two steps: Step 1 includes one infusion of Rituximab preceding In-111 ZEVALIN. Step 2 follows Step 1 by seven to nine days and consists of a second infusion of Rituximab followed by Y-90 ZEVALIN. ZEVALIN is supplied as two separate and distinctly labeled kits that contain all of the non-radioactive ingredients necessary to produce a single dose of In-111 ZEVALIN and a single dose of Y-90 ZEVALIN, both essential components of the ZEVALIN therapeutic regimen. (from http://www.rxlist.com)

Synonyms: Ibritumomab Tiuxetan

To search for Ibritumomab Tiuxetan on the web, just click the search button below.

Click on a letter to find infomation NCI Cancer and related disease terms starting with that letter.

A | B | C | D | E | F | G | H | I | J | K | L | M
N | O | P | Q | R | S | T | U | V | W | X | Y | Z